<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="6215" whole_study_id="6215" phs="000290" v="1" p="1" createDate="2010-06-07T12:15:24-05:00" completedByGPADate="2016-02-26T17:29:30-05:00" modDate="2022-01-25T16:16:05-05:00" maxParentChildStudyModDate="2022-01-25T16:16:05-05:00" handle="ESP_LungGO_PAH" num_participants="100"><StudyInfo accession="phs000290.v1.p1" parentAccession="phs000290.v1.p1"><BioProject id="PRJNA74865" entrez_id="74865" type="bp_admin_access"/><BioProject id="PRJNA74867" entrez_id="74867" type="bp_data_submission"/><StudyNameEntrez>NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Pulmonary Arterial Hypertension)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="Yes"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>analysis</StudyType><StudyType>sra</StudyType><StudyType>resequencing</StudyType></StudyTypes><SraStorages/><Description>
&lt;p&gt;The NHLBI "Grand Opportunity" Exome Sequencing Project (GO-ESP), a signature project of the NHLBI Recovery  Act investment,    was designed to identify genetic variants in coding regions (exons) of the human genome (the "exome") that are associated with    heart, lung and blood diseases.  These and related diseases that are of high impact to public health and individuals from    diverse racial and ethnic groups will be studied.  These data may help researchers understand the causes of disease,    contributing to better ways to prevent, diagnose, and treat diseases, as well as determine whether to tailor prevention    and treatments to specific populations.  This could lead to more effective treatments and reduce the likelihood of side effects.     GO-ESP is comprised of five collaborative components: 3 cohort consortia - HeartGO, LungGO, and WHISP - and 2 sequencing centers -    BroadGO and SeattleGO.&lt;/p&gt;   &lt;p&gt;The syndrome of pulmonary hypertension (PH) is a pulmonary disease that carries very high morbidity and mortality.  Pulmonary  arterial hypertension (PAH) is a category of PH (WHO Group 1) that includes several entities (idiopathic or heritable PAH, and PAH associated  with other diseases such as connective tissue diseases including scleroderma-associated PAH) and carries a dismal prognosis, in particular  when it relates to scleroderma-associated PAH (median survival of about 4 years). It is believed that the severity of structural changes  involving the pulmonary vasculature and right ventricular failure are genetically determined.  The &amp;#39;Genomics and Genetics of  Pulmonary Arterial Hypertension&amp;#39; study at Johns Hopkins University aims to identify genetic determinants associated with risk  of PAH in a cohort of European American and African American participants with and without PAH.  The study also focuses on patients  with scleroderma, who are further stratified according to those who have or do not have PAH.  The broad goals of the  Lung GO/ESP-GO falls into two general categories: (i) discovery of all variants (i.e., common and rare) in all protein-coding  regions of the human genome (i.e., the exome) conferring risk to complex pulmonary diseases including PAH.  The Johns Hopkins  University PAH cohort offers a unique opportunity to elucidate genetic variants that cause PAH.&lt;/p&gt;
 </Description><StudyHistory>
&lt;p&gt;See study description above.&lt;/p&gt;
 </StudyHistory><Attributions><Header title="Principal Investigators"><AttrName>Kathleen C. Barnes, PhD</AttrName><Institution>Johns Hopkins University, Baltimore, MD, USA</Institution></Header><Header title="Principal Investigators"><AttrName>Paul Hassoun, MD</AttrName><Institution>Johns Hopkins University, Baltimore, MD, USA</Institution></Header><Header title="Principal Investigators"><AttrName>Michael Bamshad, MD</AttrName><Institution>University of Washington, Seattle, WA, USA</Institution></Header><Header title="Principal Investigators"><AttrName>Laura K. Hummers, MD</AttrName><Institution>Johns Hopkins University, Baltimore, MD, USA</Institution></Header><Header title="Principal Investigators"><AttrName>Steve C. Mathai, MD</AttrName><Institution>Johns Hopkins University, Baltimore, MD, USA</Institution></Header><Header title="Funding Source"><AttrName>1RC2HL102923-01</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source"><AttrName>NIH P50 HL084946</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source"><AttrName>NIH K23 AR52742-01</AttrName><Institution>National Institutes of Health, Bethesda, MD, USA</Institution></Header><Header title="Funding Source"><AttrName>NHLBI F32 HL083714-01</AttrName><Institution>National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, MD, USA</Institution></Header></Attributions><StudyURLs><Url name="NHLBI GO ESP Project" url="http://esp.gs.washington.edu/drupal/"/></StudyURLs><Publications><Publication><Pubmed pmid="17907150"/></Publication><Publication><Pubmed pmid="19228661"/></Publication><Publication><Pubmed pmid="20425531"/></Publication></Publications></StudyInfo><Authority><ICs><IC id="12" name="NHLBI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="PHASSOUN" aid="2" auth="eRA" login="PHASSOUN" fname="Paul" mname="M" lname="Hassoun" email="phassoun@jhmi.edu"><Role>PI</Role><Organization>JOHNS HOPKINS UNIVERSITY</Organization></Person><Person nedid="0013114408" aid="1" auth="cit" login="ganw2" fname="Weiniu" mname="" lname="Gan" email="ganw2@mail.nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001545300" aid="1" auth="cit" login="lic17" fname="Chengyuan" mname="" lname="Press" email="chanel.press@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="3 months"><acknowledgement_statement>Exome data provided by ARRA &#8211; NHLBI Lung Cohorts Sequencing Project 1RC2HL102923-01.  The authors wish to thank the supported effort of the faculty and staff members of the Johns Hopkins University Bayview Genetics Research Facility and the Johns Hopkins University &#8216;Genomics and Genetics of Pulmonary Arterial Hypertension&#8217; program (NIH P50 HL084946, P.M. Hassoun, NIH K23 AR52742-01, L.K.  Hummers, and NHLBI F32 HL083714-01 S. C. Mathai).</acknowledgement_statement><ic_specific_access_term>Use of the data is limited only by the terms of the model Data Use Certification. </ic_specific_access_term><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="contr_access" gsr_mode_label="Controlled-access (GSR are sensitive according to the Institutional Certification)"/><ConsentGroup uid="195" CGType="cg_class_other" title="General Research Use" name="GRU" dac_uid="56" dac_name="NHLBI" irb-approval-required="No"><Use-Restriction>The use of these data is for general research purposes and has no limitations.</Use-Restriction></ConsentGroup><ConsentGroupLinks><ConsentGroupLink cg_uid_from="195"><StudyTo study_uid="10253" name="dbGaP Collection: Compilation of Individual-Level Genomic Data for General Research Use" accession="phs000688.v1"><ConsentGroupTo uid="1115" name="GRU"/></StudyTo></ConsentGroupLink><ConsentGroupLink cg_uid_from="195"><StudyTo study_uid="37911" name="NHLBI Big Data Analysis Heart Failure Challenge Data Collection" accession="phs001991.v1"><ConsentGroupTo uid="3884" name="GRU"/></StudyTo></ConsentGroupLink></ConsentGroupLinks></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>